Lifetec news
Visit and interact with the Cardiac BioSimulator at TCT San Francisco
TCT is one of the most important events of the year in the field of interventional cardiovascular medicine. As indicated before, we will have a team present to discuss potential research, development and training opportunities:
Lifetec news
Meet us at CompBioMed Conference 2019, 25-27 September, London
“The conference will address all aspects of the rapidly burgeoning domain of computational biomedicine, from genome through organ to whole human and population levels, embracing data driven, mechanistic modelling and simulation, machine learning and combinations thereof.”
Lifetec news
Platform: Cardiac BioSimulator platform: 4-chamber circulation mode
A new step has been made in the application possibilities for the Cardiac BioSimulator platform: a 4-chamber circulation mode has recently been trialed for the first time!
Lifetec news
Meet us in San Francisco @ TCT 2019
On September 25 to 29 LifeTec Group will be present at the Transcatheter Cardiovascular Therapeutics (TCT) 2019 in San Francisco California. It would be our great pleasure to meet you!
Lifetec news
Software development; a job well done!
"What started as a nice internship project, resulted in a renewal of the company’s complete software."
Lifetec news
lack of ultrasound machines in Uganda
"we heard about a very critical lack of ultrasound machines in Uganda and we happened to have two spare machines. So it was clear what needed to be done."
Lifetec news
First Coronary Artery Study in LifeTec Group's Vascular Bioreactor
A new milestone for LifeTec Group’s vascular bioreactor platform has recently been achieved: a pilot study using porcine coronary arteries has been successfully performed!
Lifetec news
Looking Back: First Semester
We’re almost at the end of the first semester of 2019, and at the beginning of the astronomical summer. Here’s our Looking Back @ First Semester:
Lifetec news
AngioSupport, designed to offer cardiologists better insights
Tim van den Boom and Bettine van Willigen are currently doing a two-year PDEng doctorate degree for Qualified Medical Engineer. They’re working on an interactive tool called AngioSupport, designed to offer cardiologists better insights into the impact of their decisions when treating coronary artery occlusions. -->>
Lifetec news
First Human Heart study at LifeTec Group’s lab!
In LifeTec Group’s lab facility in Eindhoven, the first study using human cadaveric hearts has been very successfully conducted on the Cardiac Biosimulator Platform -->>
Pages
Get in touch
Please do not hesitate to contact LifeTec Group if you require any further information: